A Reflection of the New Wave of Immunotherapy on the Clinical Study of Chinese Lung Cancer Immunotherapy
Starting from the success of anti-CTLA-4 antibody in malignant melanoma, targeted immunotherapy has become one of the effective strategies for anti-tumor therapy, and raised a new wave of research on tumor immunotherapy. In the field of lung cancer, a series of clinical studies on immune-targeted dr...
Main Authors: | Jingjing LIU, Shuang ZHANG, Shuang LI, Ying CHENG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2017-10-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2017.10.06 |
Similar Items
-
Developments in Immunotherapy for Advanced Non-small Cell Lung Cancer
by: Haoyang LI, et al.
Published: (2021-02-01) -
Progress in Immunotherapy for Non-small Cell Lung Cancer
by: Yan XU, et al.
Published: (2014-01-01) -
Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer
by: Shouzheng WANG, et al.
Published: (2016-10-01) -
New Immune Checkpoint: Advances in Immunotherapy for Malignant Tumors
by: YANG Changliang, et al.
Published: (2018-12-01) -
Clinical Efficacy and Future Prospects of Immunotherapy in Lung Cancer
by: Tomonari Kinoshita, et al.
Published: (2021-09-01)